Dr. Tofe has over fifty years of experience developing and commercializing diagnostic and therapeutic products for bone disease and bone repair, including bone graft substitute products OsteoGraf®/N and PepGen P-15®, which he took from inception through FDA approval. He has held several executive level positions including founder and CEO of CeraPedics, founder and CEO of CeraMed Dental, director of technology at Mallinckodt Medical, Vice President of Operations at Matrix Medical and marketing brand manager and section manager at Proctor & Gamble. Dr. Tofe received his B.S. in Chemistry from the University of Dayton and a Ph.D. in Inorganic/Nuclear Chemistry from Florida State University.
Friday, September 20
12:00 PM – 1:00 PM